Corporate News 31-May-24
Board of Samrat Pharmachem recommends final dividend
Of Rs 1 per share
Samrat Pharmachem announced that the Board of Directors of the Company at its meeting held on 30 May 2024, inter alia, have recommended the final dividend of Rs 1 per equity Share (i.e. 10%) , subject to the approval of the shareholders.
Previous News
Samrat Pharmachem standalone net profit rises 239.34% in the June 2024 quarter
( Results - Announcements 13-Aug-24 18:10 )
Samrat Pharmachem to declare Quarterly Result
( Corporate News - 28-Mar-23 19:47 )
Samrat Pharmachem standalone net profit rises 67.86% in the December 2019 quarter
( Results - Announcements 16-Feb-20 11:09 )
Board of Samrat Pharmachem recommends final dividend
( Corporate News - 31-May-24 10:37 )
Samrat Pharmachem net profit rises 338.71% in the September 2011 quarter
( Results - Announcements 17-Nov-11 18:07 )
Samrat Pharmachem to conduct AGM
( Corporate News - 31-May-23 15:06 )
Samrat Pharmachem to hold board meeting
( Corporate News - 27-Sep-23 11:19 )
Samrat Pharmachem net profit declines 99.50% in the June 2012 quarter
( Results - Announcements 16-Aug-12 17:38 )
Samrat Pharmachem to hold board meeting
( Corporate News - 17-Apr-17 14:16 )
Samrat Pharmachem reports standalone net loss of Rs 0.74 crore in the March 2023 quarter
( Results - Announcements 31-May-23 07:46 )
Samrat Pharmachem to hold AGM
( Corporate News - 05-Dec-20 11:12 )
Other Stories
ITD Cementation India wins order of Rs 1,937 cr
03-Oct-24 10:35
NIIT Learning Systems allots 1,666 equity shares under ESOP
03-Oct-24 10:30
Ashoka Metcast to discuss results
03-Oct-24 10:29
Emerald Finance to declare Quarterly Result
03-Oct-24 10:29
Rhetan TMT schedules board meeting
03-Oct-24 10:29
Shrenik to table results
03-Oct-24 10:29
Universal Arts to declare Quarterly Result
03-Oct-24 10:28
Three M Paper Boards to conduct board meeting
03-Oct-24 10:28
Arkade Developers to declare Quarterly Result
03-Oct-24 10:28
Worth Investment & Trading Company announces board meeting date
03-Oct-24 10:28
Back
Top
